Dactinomycin
Links shared publicly online about this topic
Bedford Laboratories launches Dactinomycin for Injection
news-medical.net — “Bedford Laboratories", a division of Ben Venue Laboratories, Inc., is pleased to announce the addition of Dactinomycin for Injection USP 500 mcg (0.5 mg) to its comprehensive line of generic oncology products. Dactinomycin was approved earlier this year by the U.S. Food and Drug Administration (FDA) and is AP rated and equivalent to Cosmegen® by Lundbeck Inc. Each single dose vial contains 0.5 mg (500mcg) of dactinomycin and 20 mg of mannitol and is individually boxed.” View full resource at news-medical.net
Most Recently Shared on July 12, 2010 at 5:46 pm By:
News-Medical.Net Oncology and Health News
Oncology News: Bedford Laboratories launches Dactinomycin for Injection: Bedford Laboratoriesâ„¢, a division of Ben ... http://bit.ly/ditnGi
Wilms Tumor: Treatment - eMedicine Urology
emedicine.medscape.com — “Treatment: Wilms tumor (WT) is the fifth most common pediatric malignancy and the most common type of renal tumor in children. The treatment used to treat Wilms tumor is an example of success achieved through a multidisciplinary collaboration ...” View full resource at emedicine.medscape.com
Most Recently Shared on September 23, 2010 at 12:38 am By:
Julie Bohlen Active Health Library and Health Executive
Just added http://bit.ly/cZK4eA to the Wilms Tumor Treatment WisdomCard http://bit.ly/cqZsZq @organizedwisdom
Oncology Article | Gestational Trophoblastic Neoplasms
mdlinx.com — “Salvage combination chemotherapy with floxuridine, dactinomycin, etoposide, and vincristine (FAEV) for patients with relapsed/chemoresistant gestational trophoblastic neoplasia” View full resource at mdlinx.com
Most Recently Shared on January 24, 2011 at 8:12 am By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Salvage combination chemotherapy with floxuridine, dactinomycin, etoposide, and vincristine (FAEV) for... http://bit.ly/fWHlq8 #oncology
Pediatrics Article | Cancer
mdlinx.com — “Dactinomycin and vincristine toxicity in the treatment of childhood cancer: A retrospective study from the Children's Oncology Group” View full resource at mdlinx.com
Most Recently Shared on December 22, 2010 at 1:58 am By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Dactinomycin and vincristine toxicity in the treatment of childhood cancer: A retrospective study from the... http://bit.ly/gN2xca #peds
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
News-Medical.Net
Stay up to date with the latest Oncology news and research via News-Medical.Net
-
Julie Bohlen
Health content professional with MBA in heathcare management. Sharing quality health resources and news. On executive team at OrganizedWisdom.
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement
